Patients who are hospitalized in intensive care units ICUs , patients who have undergone certain types of surgeries, and patients with medical devices inserted in their bodies, such as central lines and catheters, are at greater risk of a more serious S.
People who often visit healthcare facilities and nursing home residents are also at an increased risk. Treatment depends on the type of infection caused by the bacteria.
When antibiotics are prescribed, they are selected based on laboratory testing of the bacteria and may involve more than one type. Links with this icon indicate that you are leaving the CDC website. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link. CDC is not responsible for Section compliance accessibility on other federal or private website. Cancel Continue. Nasal carriage as a source of Staphylococcus aureus bacteremia. Foster, T. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Vanhommerig, E. Comparison of biofilm formation between major clonal lineages of methicillin resistant Staphylococcus aureus.
Neutrophils versus Staphylococcus aureus: a biological tug of war. Hanzelmann, D. Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants. Cheng, A. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. Laarman, A. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
Stapels, D. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors. Natl Acad. USA , — Peschel, A. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Loffler, B. Staphylococcus aureus panton—valentine leukocidin is a very potent cytotoxic factor for human neutrophils.
Spaulding, A. Staphylococcal and streptococcal superantigen exotoxins. Chavakis, T. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. Staphylococcus aureus persistence in non-professional phagocytes. Thomer, L. Pathogenesis of Staphylococcus aureus bloodstream infections. Le, K. Quorum-sensing regulation in staphylococci-an overview. Cheung, G.
Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Kaito, C. Painter, K. What role does the quorum-sensing accessory gene regulator system play during Staphylococcus aureus bacteremia? Crisostomo, M. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones.
USA 98 , — Bal, A. Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: Blurring of the traditional definitions. Resist 6 , 95— Hartman, B. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. Garcia-Alvarez, L. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study.
Kim, C. Milheirico, C. Full-genome sequencing identifies in the genetic background several determinants that modulate the resistance phenotype in methicillin-resistant Staphylococcus aureus strains carrying the novel mecC gene. Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus.
Hiramatsu, K. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus MRSA.
Arede, P. The anti-repressor MecR2 promotes the proteolysis of the mecA repressor and enables optimal expression of beta-lactam resistance in MRSA. Zhang, H. A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci. Science , — De Lencastre, H. Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin.
Drug Resist 5 , — The mechanism of heterogeneous beta-lactam resistance in MRSA: key role of the stringent stress response. FEMS Microbiol. Jousselin, A. The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A.
Agents Chemother 60 , — Agents Chemother 61 , e Gardete, S. Mechanisms of vancomycin resistance in Staphylococcus aureus. This is a comprehensive review of the mechanisms of vancomycin resistance in S. Klevens, R. Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
JAMA , — Epstein, L. Risk factors for invasive methicillin-resistant Staphylococcus aureus infection after recent discharge from an acute-care hospitalization, — Davis, K. Francis, J. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton—Valentine leukocidin genes. Miller, L. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.
Kazakova, S. A clone of methicillin-resistant Staphylococcus aureus among professional football players. Aiello, A. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Drougka, E. Clinical and Laboratory Standards Institute. Ryffel, C. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Penn, C. Wound infections caused by inducible meticillin-resistant Staphylococcus aureus strains.
Resist 1 , 79—83 Winstanley, T. Expert systems in clinical microbiology. This reference is a good overview of automated systems for the detection of resistance mechanisms with a critical review of published evaluations of the performance of each system. Bhowmick, T. Controlled multicenter evaluation of a bacteriophage-based method for rapid detection of Staphylococcus aureus in positive blood cultures.
Opota, O. Blood culture-based diagnosis of bacteraemia: state of the art. Romero-Gomez, M. Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management. Malhotra-Kumar, S. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. Malhotra- Kumar, S. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus.
Blaschke, A. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Almuhayawi, M. Identification of microorganisms by FilmArray and matrix-assisted laser desorption ionization-time of flight mass spectrometry prior to positivity in the blood culture system. Cao, M. Streaming algorithms for identification of pathogens and antibiotic resistance potential from real-time MinION TM sequencing.
GigaScience 5 , 32 Aanensen, D. Whole-genome sequencing for routine pathogen surveillance in public health: a population snapshot of invasive Staphylococcus aureus in Europe. Koser, C. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. Millar, E. Merlino, J. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S.
Perry, J. Decade of development of chromogenic culture media for clinical microbiology in an era of molecular diagnostics. Tqhis is a comprehensive reference reviewing rapid culture methods for the detection of MRSA and other multidrug-resistant organisms. Gazin, M. Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study.
Luthje, P. Methods , 17—20 Faron, M. Automated scoring of chromogenic media for detection of methicillin-resistant Staphylococcus aureus by use of WASPLab image analysis software. Cunningham, R. Derde, L. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Wu, P. Point-of-care universal screening for meticillin-resistant Staphylococcus aureus: a cluster-randomized cross-over trial.
Calfee, D. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: update. This paper is an expert guidance document, with grading of the quality of the evidence, for MRSA control in acute care facilities.
World Health Organization. Sax, H. Pittet, D. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet , — Stone, S. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study.
BMJ , e Salgado, C. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures?
Robicsek, A. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Harbarth, S. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. Lee, A. Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial.
BMJ Open 3 , e Robotham, J. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
Huskins, W. Intervention to reduce transmission of resistant bacteria in intensive care. Harris, A. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.
Cepeda, J. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Fatkenheuer, G. Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. This commentary provides an update regarding the growing evidence for and against the role of active surveillance in MRSA control. Loeb, M.
Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst. Poovelikunnel, T. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. Landelle, C. Randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy of polyhexanide for topical decolonization of MRSA carriers.
Bode, L. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery. Huang, S. Targeted versus universal decolonization to prevent ICU infection.
Ammerlaan, H. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess.
Daum, R. A placebo-controlled trial of antibiotics for smaller skin abscesses. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
This paper represents an essential and up-to-date guidance document for management of MRSA infection. Gould, I. New insights into meticillin-resistant Staphylococcus aureus MRSA pathogenesis, treatment and resistance. Agents 39 , 96— Svetitsky, S. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Vandecasteele, S. The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. Lodise, T.
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Cataldo, M. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. Bradley, J. Which antibiotic for resistant Gram-positives, and why?
Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Cosgrove, S. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.
Fowler, V. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Thwaites, G. Clinical management of Staphylococcus aureus bacteraemia.
This is an important reference for all persons interested in the optimal treatment of S. Houlihan, H. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Tsuji, B. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Rehm, S. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Bayer, A. Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic? Forrest, G. Rifampin combination therapy for nonmycobacterial infections. Adjunctive rifampicin for Staphylococcus aureus bacteraemia ARREST : a multicentre, randomised, double-blind, placebo-controlled trial. Davis, J. Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial.
Sakoulas, G. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Rose, W. Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infections.
Cosimi, R. Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review. Open Forum Infect. Tattevin, P. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Oltolini, C. Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy. Agents 47 , — Andrey, D. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus MRSA isolates collected in — at the Geneva University Hospitals. Long, S. PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
Zhanel, G. New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin. Drugs 70 , — McCurdy, S. In vitro activity of dalbavancin against drug-resistant Staphylococcus aureus isolates from a global surveillance program.
Werth, B. Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus VISA after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen. Yaw, L. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
How deadly is meticillin-resistant Staphylococcus aureus? De Angelis, G. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients. Estimating the impact of healthcare-associated infections on length of stay and costs. Stewardson, A. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, and a multicentre retrospective cohort study.
Eurosurveillance 21 , This is a methodologically sound analysis of excess length of stay of MRSA bacteraemia. PubMed Central Google Scholar. Haessler, S. Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus.
Pendleton, A. Methicillin-resistant Staphylococcus aureus bone and joint infections in children. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Gleeson, A. The impact of meticillin-resistant Staphylococcus aureus on patients with advanced cancer and their family members: a qualitative study. Health and health-related quality of life in pig farmers carrying livestock-associated methicillin-resistant Staphylococcus aureus.
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. This is most likely the best paper evaluating the question of whether MRSA adds to the overall burden of nosocomial infections. Jones, B. Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across US veterans affairs medical centers.
Herr, C. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Pozzi, C. Vaccines for Staphylococcus aureus and target populations. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
Shinefield, H. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. Where does a Staphylococcus aureus vaccine stand? Stentzel, S. Specific serum IgG at diagnosis of Staphylococcus aureus bloodstream invasion is correlated with disease progression.
Kurokawa, K. The staphylococcal surface-glycopolymer wall teichoic acid WTA is crucial for complement activation and immunological defense against Staphylococcus aureus infection.
Immunobiology , — Bekeredjian-Ding, I. Deciphering the significance of the T cell response to Staphylococcus aureus. Future Microbiol.
Lehar, S. Novel antibody-antibiotic conjugate eliminates intracellular S. Idelevich, E. In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF, a recombinant chimeric bacteriophage endolysin. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Mwangi, M. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Howden, B. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
Khatib, R. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. Satola, S. Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. Sievert, D. Vancomycin-resistant Staphylococcus aureus in the United States, — Weigel, L.
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Foucault, M. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Stefani, S. Meticillin-resistant Staphylococcus aureus MRSA : global epidemiology and harmonisation of typing methods.
0コメント